143096-35-9

Upstream product

• 2835-95-2 amino-4 hydroxy-2 toluene 
• 3282-30-2 pivaloyl chloride 
• 143096-34-8 N-(3-methoxy-4-methylphenyl)-2,2-dimethylpropanamide 
• 124-38-9 carbon dioxide 
• 1312305-91-1 N-(3-hydroxy-4-methylphenyl)-2,2-dimethylpropionamide 

Downstream Products

• 1374139-14-6 methyl 6-{2-(benzyloxy)-4-methyl-6-{[(tetrahydro-2H-pyran-2-yl)oxy]methyl}phenoxy}-3-formyl-2-methoxybenzoate 
• 1374139-15-7 methyl 6-[2-(benzyloxy)-6-(hydroxymethyl)-4-methylphenoxy]-3-formyl-2-methoxybenzoate 
• 1374139-16-8 6-[2-(benzyloxy)-6-(hydroxymethyl)-4-methylphenoxy]-3-formyl-2-methoxybenzoic acid 
• 1374139-17-9 11-(benzyloxy)-4-methoxy-9-methyl-5-oxo-5,7-dihydrodibenzo-[b,g][1,5]-dioxocine-3-carbaldehyde 
• 1374139-18-0 11-(benzyloxy)-3-(1-hydroxy-3-methylbut-3-en-1-yl)-4-methoxy-9-methyl-5H,7H-dibenzo[b,g][1,5]-dioxocin-5-one 
• 143096-37-1 methyl 6-bromo-2-methoxy-3-methylbenzoate 
• 1374139-09-9 methyl 6-bromo-3-(dibromomethyl)-2-methoxybenzoate 
• 143096-38-2 methyl 6-bromo-3-formyl-2-methoxybenzoate 
• 1383452-10-5 2-methoxy-3-(methylcarbamoyl)-4-pivalamidobenzoicacid 
• 1383452-09-2 2-methoxy-N,3-dimethyl-6-pivalamidobenzamide 
• 1383452-36-5 N-(4-fluorobenzyl)-5-hydroxy-3-methyl-2-(4-nitrobenzyl)-4-oxo-3,4-dihydroquinazoline-6-carboxamide 
• 1383452-35-4 n,2-bis(4-fluorobenzyl)-5-hydroxy-3-methyl-4-oxo-3,4-dihydroquinazoline-6-carboxamide 
• 1383452-34-3 2-butyl-N-(4-fluorobenzyl)-5-hydroxy-3-methyl-4-oxo-3,4-dihydroquinazoline-6-carboxamide 
• 1383452-33-2 N-(4-fluorobenzyl)-5-hydroxy-3-methyl-4-oxo-2-(pyridin-2-yl)-3,4-dihydroquinazoline-6-carboxamide 

Relevant academic research and scientific papers

A convergent approach to dibenzodioxocinones: Synthesis of racemic penicillide

A convergent approach to dibenzodioxocinones was explored, thereby racemic penicillide ((±)-1a) could be obtained in 13 steps in 4.2% overall yield, based on 5-amino-2-methylphenol (5) (Schemes 2-4).

Design, synthesis and antiviral activity of novel quinazolinones

HIV-1 integrase (IN) is a validated therapeutic target for antiviral drug design. However, the emergence of viral strains resistant to clinically studied IN inhibitors demands the discovery of novel inhibitors that are structurally as well as mechanistica

Substituted dibenz-oxa-thiocinones, -12-oxides and -12,12-dioxides, a process for their preparation and their use in medicaments

The invention relates to substituted dibenz-oxa-thiocinone-12-oxides and -12,12-dioxides of the general formula I STR1 in which R1 to R6 and Y have the meaning indicated in the description, to processes for their preparation and to their use in medicaments, in particular in circulation-influencing medicaments.